nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—CYP1A2—Erlotinib—lung cancer	0.0532	0.117	CbGbCtD
Levobupivacaine—CYP3A4—Topotecan—lung cancer	0.0516	0.113	CbGbCtD
Levobupivacaine—CYP3A4—Gefitinib—lung cancer	0.0472	0.104	CbGbCtD
Levobupivacaine—CYP3A4—Teniposide—lung cancer	0.0457	0.101	CbGbCtD
Levobupivacaine—CYP1A2—Etoposide—lung cancer	0.0385	0.0846	CbGbCtD
Levobupivacaine—CYP3A4—Vinorelbine—lung cancer	0.0363	0.0799	CbGbCtD
Levobupivacaine—CYP3A4—Crizotinib—lung cancer	0.0289	0.0636	CbGbCtD
Levobupivacaine—CYP3A4—Erlotinib—lung cancer	0.0279	0.0613	CbGbCtD
Levobupivacaine—CYP3A4—Paclitaxel—lung cancer	0.0255	0.0561	CbGbCtD
Levobupivacaine—CYP3A4—Irinotecan—lung cancer	0.0252	0.0554	CbGbCtD
Levobupivacaine—CYP3A4—Vinblastine—lung cancer	0.0224	0.0492	CbGbCtD
Levobupivacaine—CYP3A4—Etoposide—lung cancer	0.0202	0.0443	CbGbCtD
Levobupivacaine—CYP3A4—Docetaxel—lung cancer	0.0185	0.0406	CbGbCtD
Levobupivacaine—CYP3A4—Doxorubicin—lung cancer	0.0138	0.0302	CbGbCtD
Levobupivacaine—Lidocaine—EGFR—lung cancer	0.00143	0.395	CrCbGaD
Levobupivacaine—Lidocaine—CYP2A6—lung cancer	0.00117	0.322	CrCbGaD
Levobupivacaine—Tocainide—ALB—lung cancer	0.000589	0.163	CrCbGaD
Levobupivacaine—Lidocaine—ABCB1—lung cancer	0.000434	0.12	CrCbGaD
Levobupivacaine—Oedema—Paclitaxel—lung cancer	0.000205	0.000475	CcSEcCtD
Levobupivacaine—Paraesthesia—Cisplatin—lung cancer	0.000205	0.000475	CcSEcCtD
Levobupivacaine—Muscle spasms—Docetaxel—lung cancer	0.000205	0.000474	CcSEcCtD
Levobupivacaine—Tachycardia—Etoposide—lung cancer	0.000204	0.000473	CcSEcCtD
Levobupivacaine—Infection—Paclitaxel—lung cancer	0.000204	0.000472	CcSEcCtD
Levobupivacaine—Dyspnoea—Cisplatin—lung cancer	0.000204	0.000471	CcSEcCtD
Levobupivacaine—Skin disorder—Etoposide—lung cancer	0.000203	0.00047	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Etoposide—lung cancer	0.000202	0.000468	CcSEcCtD
Levobupivacaine—Feeling abnormal—Gemcitabine—lung cancer	0.000202	0.000467	CcSEcCtD
Levobupivacaine—Shock—Paclitaxel—lung cancer	0.000202	0.000467	CcSEcCtD
Levobupivacaine—Dizziness—Vinorelbine—lung cancer	0.000202	0.000467	CcSEcCtD
Levobupivacaine—Orthostatic hypotension—Doxorubicin—lung cancer	0.000202	0.000467	CcSEcCtD
Levobupivacaine—Nervous system disorder—Paclitaxel—lung cancer	0.000201	0.000466	CcSEcCtD
Levobupivacaine—Tachycardia—Paclitaxel—lung cancer	0.0002	0.000463	CcSEcCtD
Levobupivacaine—Skin disorder—Paclitaxel—lung cancer	0.000199	0.000461	CcSEcCtD
Levobupivacaine—Body temperature increased—Irinotecan—lung cancer	0.000199	0.00046	CcSEcCtD
Levobupivacaine—Abdominal pain—Irinotecan—lung cancer	0.000199	0.00046	CcSEcCtD
Levobupivacaine—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000199	0.00046	CcSEcCtD
Levobupivacaine—Decreased appetite—Cisplatin—lung cancer	0.000199	0.000459	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Paclitaxel—lung cancer	0.000199	0.000459	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Cisplatin—lung cancer	0.000197	0.000456	CcSEcCtD
Levobupivacaine—Anaemia—Docetaxel—lung cancer	0.000197	0.000456	CcSEcCtD
Levobupivacaine—Infestation NOS—Methotrexate—lung cancer	0.000197	0.000455	CcSEcCtD
Levobupivacaine—Drowsiness—Methotrexate—lung cancer	0.000197	0.000455	CcSEcCtD
Levobupivacaine—Infestation—Methotrexate—lung cancer	0.000197	0.000455	CcSEcCtD
Levobupivacaine—Hypotension—Etoposide—lung cancer	0.000196	0.000452	CcSEcCtD
Levobupivacaine—Pain—Cisplatin—lung cancer	0.000196	0.000452	CcSEcCtD
Levobupivacaine—Muscular weakness—Doxorubicin—lung cancer	0.000195	0.000451	CcSEcCtD
Levobupivacaine—Alanine aminotransferase increased—Doxorubicin—lung cancer	0.000195	0.000451	CcSEcCtD
Levobupivacaine—Vomiting—Vinorelbine—lung cancer	0.000194	0.000449	CcSEcCtD
Levobupivacaine—Body temperature increased—Gemcitabine—lung cancer	0.000194	0.000448	CcSEcCtD
Levobupivacaine—Abdominal distension—Doxorubicin—lung cancer	0.000192	0.000445	CcSEcCtD
Levobupivacaine—Hypotension—Paclitaxel—lung cancer	0.000192	0.000444	CcSEcCtD
Levobupivacaine—Headache—Vinorelbine—lung cancer	0.000191	0.000442	CcSEcCtD
Levobupivacaine—Syncope—Docetaxel—lung cancer	0.000191	0.000442	CcSEcCtD
Levobupivacaine—Dysphagia—Doxorubicin—lung cancer	0.000191	0.000442	CcSEcCtD
Levobupivacaine—Sweating—Methotrexate—lung cancer	0.000189	0.000436	CcSEcCtD
Levobupivacaine—Palpitations—Docetaxel—lung cancer	0.000188	0.000436	CcSEcCtD
Levobupivacaine—Feeling abnormal—Cisplatin—lung cancer	0.000188	0.000436	CcSEcCtD
Levobupivacaine—Paraesthesia—Etoposide—lung cancer	0.000188	0.000435	CcSEcCtD
Levobupivacaine—Haematuria—Methotrexate—lung cancer	0.000188	0.000434	CcSEcCtD
Levobupivacaine—Loss of consciousness—Docetaxel—lung cancer	0.000187	0.000433	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000187	0.000433	CcSEcCtD
Levobupivacaine—Dyspnoea—Etoposide—lung cancer	0.000187	0.000432	CcSEcCtD
Levobupivacaine—Somnolence—Etoposide—lung cancer	0.000186	0.000431	CcSEcCtD
Levobupivacaine—Cough—Docetaxel—lung cancer	0.000186	0.00043	CcSEcCtD
Levobupivacaine—Insomnia—Paclitaxel—lung cancer	0.000186	0.000429	CcSEcCtD
Levobupivacaine—Hypersensitivity—Irinotecan—lung cancer	0.000186	0.000429	CcSEcCtD
Levobupivacaine—Convulsion—Docetaxel—lung cancer	0.000185	0.000427	CcSEcCtD
Levobupivacaine—Paraesthesia—Paclitaxel—lung cancer	0.000184	0.000426	CcSEcCtD
Levobupivacaine—Hypertension—Docetaxel—lung cancer	0.000184	0.000426	CcSEcCtD
Levobupivacaine—Dyspnoea—Paclitaxel—lung cancer	0.000183	0.000423	CcSEcCtD
Levobupivacaine—Somnolence—Paclitaxel—lung cancer	0.000183	0.000422	CcSEcCtD
Levobupivacaine—Decreased appetite—Etoposide—lung cancer	0.000182	0.000421	CcSEcCtD
Levobupivacaine—Arthralgia—Docetaxel—lung cancer	0.000182	0.00042	CcSEcCtD
Levobupivacaine—Nausea—Vinorelbine—lung cancer	0.000181	0.000419	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Etoposide—lung cancer	0.000181	0.000418	CcSEcCtD
Levobupivacaine—Dyspepsia—Paclitaxel—lung cancer	0.000181	0.000418	CcSEcCtD
Levobupivacaine—Body temperature increased—Cisplatin—lung cancer	0.000181	0.000418	CcSEcCtD
Levobupivacaine—Asthenia—Irinotecan—lung cancer	0.000181	0.000418	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.00018	0.000417	CcSEcCtD
Levobupivacaine—Constipation—Etoposide—lung cancer	0.000179	0.000414	CcSEcCtD
Levobupivacaine—Pain—Etoposide—lung cancer	0.000179	0.000414	CcSEcCtD
Levobupivacaine—Decreased appetite—Paclitaxel—lung cancer	0.000179	0.000413	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000177	0.00041	CcSEcCtD
Levobupivacaine—Asthenia—Gemcitabine—lung cancer	0.000176	0.000407	CcSEcCtD
Levobupivacaine—Pain—Paclitaxel—lung cancer	0.000176	0.000406	CcSEcCtD
Levobupivacaine—Constipation—Paclitaxel—lung cancer	0.000176	0.000406	CcSEcCtD
Levobupivacaine—Confusional state—Docetaxel—lung cancer	0.000176	0.000406	CcSEcCtD
Levobupivacaine—Oedema—Docetaxel—lung cancer	0.000174	0.000402	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Docetaxel—lung cancer	0.000174	0.000402	CcSEcCtD
Levobupivacaine—Pruritus—Gemcitabine—lung cancer	0.000174	0.000401	CcSEcCtD
Levobupivacaine—Infection—Docetaxel—lung cancer	0.000173	0.0004	CcSEcCtD
Levobupivacaine—Feeling abnormal—Etoposide—lung cancer	0.000173	0.000399	CcSEcCtD
Levobupivacaine—Diarrhoea—Irinotecan—lung cancer	0.000172	0.000398	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Etoposide—lung cancer	0.000171	0.000396	CcSEcCtD
Levobupivacaine—Shock—Docetaxel—lung cancer	0.000171	0.000396	CcSEcCtD
Levobupivacaine—Nervous system disorder—Docetaxel—lung cancer	0.000171	0.000395	CcSEcCtD
Levobupivacaine—Infestation NOS—Doxorubicin—lung cancer	0.00017	0.000394	CcSEcCtD
Levobupivacaine—Infestation—Doxorubicin—lung cancer	0.00017	0.000394	CcSEcCtD
Levobupivacaine—Drowsiness—Doxorubicin—lung cancer	0.00017	0.000394	CcSEcCtD
Levobupivacaine—Tachycardia—Docetaxel—lung cancer	0.00017	0.000393	CcSEcCtD
Levobupivacaine—Feeling abnormal—Paclitaxel—lung cancer	0.000169	0.000391	CcSEcCtD
Levobupivacaine—Skin disorder—Docetaxel—lung cancer	0.000169	0.000391	CcSEcCtD
Levobupivacaine—Hypersensitivity—Cisplatin—lung cancer	0.000168	0.000389	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Paclitaxel—lung cancer	0.000168	0.000388	CcSEcCtD
Levobupivacaine—Diarrhoea—Gemcitabine—lung cancer	0.000168	0.000388	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Doxorubicin—lung cancer	0.000167	0.000386	CcSEcCtD
Levobupivacaine—Dizziness—Irinotecan—lung cancer	0.000167	0.000385	CcSEcCtD
Levobupivacaine—Urticaria—Etoposide—lung cancer	0.000166	0.000385	CcSEcCtD
Levobupivacaine—Abdominal pain—Etoposide—lung cancer	0.000166	0.000383	CcSEcCtD
Levobupivacaine—Body temperature increased—Etoposide—lung cancer	0.000166	0.000383	CcSEcCtD
Levobupivacaine—Urinary tract infection—Doxorubicin—lung cancer	0.000166	0.000383	CcSEcCtD
Levobupivacaine—Tinnitus—Methotrexate—lung cancer	0.000165	0.000381	CcSEcCtD
Levobupivacaine—Asthenia—Cisplatin—lung cancer	0.000164	0.000379	CcSEcCtD
Levobupivacaine—Cardiac disorder—Methotrexate—lung cancer	0.000164	0.000379	CcSEcCtD
Levobupivacaine—Sweating—Doxorubicin—lung cancer	0.000163	0.000378	CcSEcCtD
Levobupivacaine—Urticaria—Paclitaxel—lung cancer	0.000163	0.000377	CcSEcCtD
Levobupivacaine—Hypotension—Docetaxel—lung cancer	0.000163	0.000376	CcSEcCtD
Levobupivacaine—Haematuria—Doxorubicin—lung cancer	0.000162	0.000375	CcSEcCtD
Levobupivacaine—Abdominal pain—Paclitaxel—lung cancer	0.000162	0.000375	CcSEcCtD
Levobupivacaine—Body temperature increased—Paclitaxel—lung cancer	0.000162	0.000375	CcSEcCtD
Levobupivacaine—Vomiting—Irinotecan—lung cancer	0.00016	0.00037	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000159	0.000367	CcSEcCtD
Levobupivacaine—Chills—Methotrexate—lung cancer	0.000158	0.000366	CcSEcCtD
Levobupivacaine—Headache—Irinotecan—lung cancer	0.000158	0.000365	CcSEcCtD
Levobupivacaine—Insomnia—Docetaxel—lung cancer	0.000157	0.000364	CcSEcCtD
Levobupivacaine—Diarrhoea—Cisplatin—lung cancer	0.000156	0.000362	CcSEcCtD
Levobupivacaine—Paraesthesia—Docetaxel—lung cancer	0.000156	0.000361	CcSEcCtD
Levobupivacaine—Vomiting—Gemcitabine—lung cancer	0.000156	0.000361	CcSEcCtD
Levobupivacaine—Bradycardia—Doxorubicin—lung cancer	0.000156	0.00036	CcSEcCtD
Levobupivacaine—Dyspnoea—Docetaxel—lung cancer	0.000155	0.000359	CcSEcCtD
Levobupivacaine—Somnolence—Docetaxel—lung cancer	0.000155	0.000358	CcSEcCtD
Levobupivacaine—Mental disorder—Methotrexate—lung cancer	0.000155	0.000358	CcSEcCtD
Levobupivacaine—Hypersensitivity—Etoposide—lung cancer	0.000154	0.000357	CcSEcCtD
Levobupivacaine—Erythema—Methotrexate—lung cancer	0.000154	0.000355	CcSEcCtD
Levobupivacaine—Malnutrition—Methotrexate—lung cancer	0.000154	0.000355	CcSEcCtD
Levobupivacaine—Headache—Gemcitabine—lung cancer	0.000154	0.000355	CcSEcCtD
Levobupivacaine—Dyspepsia—Docetaxel—lung cancer	0.000153	0.000354	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Doxorubicin—lung cancer	0.000152	0.000352	CcSEcCtD
Levobupivacaine—Decreased appetite—Docetaxel—lung cancer	0.000151	0.00035	CcSEcCtD
Levobupivacaine—Hypersensitivity—Paclitaxel—lung cancer	0.000151	0.00035	CcSEcCtD
Levobupivacaine—Oedema peripheral—Doxorubicin—lung cancer	0.000151	0.000348	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Docetaxel—lung cancer	0.00015	0.000347	CcSEcCtD
Levobupivacaine—Asthenia—Etoposide—lung cancer	0.00015	0.000347	CcSEcCtD
Levobupivacaine—Nausea—Irinotecan—lung cancer	0.00015	0.000346	CcSEcCtD
Levobupivacaine—Constipation—Docetaxel—lung cancer	0.000149	0.000344	CcSEcCtD
Levobupivacaine—Pain—Docetaxel—lung cancer	0.000149	0.000344	CcSEcCtD
Levobupivacaine—Back pain—Methotrexate—lung cancer	0.000149	0.000344	CcSEcCtD
Levobupivacaine—Pruritus—Etoposide—lung cancer	0.000148	0.000343	CcSEcCtD
Levobupivacaine—Asthenia—Paclitaxel—lung cancer	0.000147	0.000341	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—ERBB2—lung cancer	0.000146	0.00134	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—COL4A3BP—lung cancer	0.000146	0.00134	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—KDR—lung cancer	0.000146	0.00134	CbGpPWpGaD
Levobupivacaine—Nausea—Gemcitabine—lung cancer	0.000146	0.000337	CcSEcCtD
Levobupivacaine—Vomiting—Cisplatin—lung cancer	0.000145	0.000336	CcSEcCtD
Levobupivacaine—Pruritus—Paclitaxel—lung cancer	0.000145	0.000336	CcSEcCtD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTP1—lung cancer	0.000145	0.00133	CbGpPWpGaD
Levobupivacaine—Vision blurred—Methotrexate—lung cancer	0.000145	0.000335	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000143	0.00132	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Docetaxel—lung cancer	0.000143	0.000332	CcSEcCtD
Levobupivacaine—Diarrhoea—Etoposide—lung cancer	0.000143	0.000331	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—MET—lung cancer	0.000143	0.00131	CbGpPWpGaD
Levobupivacaine—Tinnitus—Doxorubicin—lung cancer	0.000143	0.00033	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Docetaxel—lung cancer	0.000142	0.000329	CcSEcCtD
Levobupivacaine—Anaemia—Methotrexate—lung cancer	0.000142	0.000328	CcSEcCtD
Levobupivacaine—Cardiac disorder—Doxorubicin—lung cancer	0.000142	0.000328	CcSEcCtD
Levobupivacaine—Flushing—Doxorubicin—lung cancer	0.000142	0.000328	CcSEcCtD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.000142	0.0013	CbGpPWpGaD
Levobupivacaine—Diarrhoea—Paclitaxel—lung cancer	0.000141	0.000325	CcSEcCtD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000139	0.00128	CbGpPWpGaD
Levobupivacaine—Dizziness—Etoposide—lung cancer	0.000139	0.00032	CcSEcCtD
Levobupivacaine—Body temperature increased—Docetaxel—lung cancer	0.000138	0.000318	CcSEcCtD
Levobupivacaine—Abdominal pain—Docetaxel—lung cancer	0.000138	0.000318	CcSEcCtD
Levobupivacaine—Chills—Doxorubicin—lung cancer	0.000137	0.000317	CcSEcCtD
Levobupivacaine—Arrhythmia—Doxorubicin—lung cancer	0.000137	0.000316	CcSEcCtD
Levobupivacaine—Dizziness—Paclitaxel—lung cancer	0.000136	0.000314	CcSEcCtD
Levobupivacaine—Nausea—Cisplatin—lung cancer	0.000136	0.000314	CcSEcCtD
Levobupivacaine—Cough—Methotrexate—lung cancer	0.000134	0.00031	CcSEcCtD
Levobupivacaine—Mental disorder—Doxorubicin—lung cancer	0.000134	0.00031	CcSEcCtD
Levobupivacaine—CYP1A2—Phase II conjugation—GSTM1—lung cancer	0.000133	0.00122	CbGpPWpGaD
Levobupivacaine—Convulsion—Methotrexate—lung cancer	0.000133	0.000308	CcSEcCtD
Levobupivacaine—Vomiting—Etoposide—lung cancer	0.000133	0.000308	CcSEcCtD
Levobupivacaine—Malnutrition—Doxorubicin—lung cancer	0.000133	0.000308	CcSEcCtD
Levobupivacaine—Erythema—Doxorubicin—lung cancer	0.000133	0.000308	CcSEcCtD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000133	0.00122	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.000131	0.0012	CbGpPWpGaD
Levobupivacaine—Headache—Etoposide—lung cancer	0.000131	0.000303	CcSEcCtD
Levobupivacaine—Flatulence—Doxorubicin—lung cancer	0.000131	0.000303	CcSEcCtD
Levobupivacaine—CYP1A2—Tryptophan metabolism—MDM2—lung cancer	0.000131	0.0012	CbGpPWpGaD
Levobupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.000131	0.0012	CbGpPWpGaD
Levobupivacaine—Arthralgia—Methotrexate—lung cancer	0.000131	0.000303	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—lung cancer	0.000131	0.0012	CbGpPWpGaD
Levobupivacaine—Tension—Doxorubicin—lung cancer	0.000131	0.000302	CcSEcCtD
Levobupivacaine—Vomiting—Paclitaxel—lung cancer	0.000131	0.000302	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—MMP9—lung cancer	0.00013	0.00119	CbGpPWpGaD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.00013	0.0003	CcSEcCtD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000129	0.00119	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6R—lung cancer	0.000129	0.00119	CbGpPWpGaD
Levobupivacaine—Nervousness—Doxorubicin—lung cancer	0.000129	0.000299	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—CREBBP—lung cancer	0.000129	0.00119	CbGpPWpGaD
Levobupivacaine—Back pain—Doxorubicin—lung cancer	0.000129	0.000298	CcSEcCtD
Levobupivacaine—Headache—Paclitaxel—lung cancer	0.000129	0.000297	CcSEcCtD
Levobupivacaine—Hypersensitivity—Docetaxel—lung cancer	0.000128	0.000297	CcSEcCtD
Levobupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	0.000128	0.00118	CbGpPWpGaD
Levobupivacaine—Muscle spasms—Doxorubicin—lung cancer	0.000128	0.000296	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000128	0.00117	CbGpPWpGaD
Levobupivacaine—Confusional state—Methotrexate—lung cancer	0.000127	0.000292	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—lung cancer	0.000126	0.00116	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—HPGDS—lung cancer	0.000126	0.00116	CbGpPWpGaD
Levobupivacaine—Anaphylactic shock—Methotrexate—lung cancer	0.000125	0.00029	CcSEcCtD
Levobupivacaine—Vision blurred—Doxorubicin—lung cancer	0.000125	0.00029	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—MMP9—lung cancer	0.000125	0.00115	CbGpPWpGaD
Levobupivacaine—Asthenia—Docetaxel—lung cancer	0.000125	0.000289	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—IL6R—lung cancer	0.000125	0.00114	CbGpPWpGaD
Levobupivacaine—Infection—Methotrexate—lung cancer	0.000125	0.000288	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—CREBBP—lung cancer	0.000125	0.00114	CbGpPWpGaD
Levobupivacaine—Nausea—Etoposide—lung cancer	0.000124	0.000288	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—MMP2—lung cancer	0.000124	0.00113	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000123	0.00113	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MAP2K1—lung cancer	0.000123	0.00113	CbGpPWpGaD
Levobupivacaine—Pruritus—Docetaxel—lung cancer	0.000123	0.000285	CcSEcCtD
Levobupivacaine—Nervous system disorder—Methotrexate—lung cancer	0.000123	0.000284	CcSEcCtD
Levobupivacaine—Anaemia—Doxorubicin—lung cancer	0.000123	0.000284	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—GSTT1—lung cancer	0.000123	0.00112	CbGpPWpGaD
Levobupivacaine—Agitation—Doxorubicin—lung cancer	0.000122	0.000283	CcSEcCtD
Levobupivacaine—Nausea—Paclitaxel—lung cancer	0.000122	0.000282	CcSEcCtD
Levobupivacaine—Skin disorder—Methotrexate—lung cancer	0.000122	0.000282	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Methotrexate—lung cancer	0.000121	0.00028	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—GCLC—lung cancer	0.000121	0.00111	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2A6—lung cancer	0.000121	0.00111	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—SRC—lung cancer	0.00012	0.0011	CbGpPWpGaD
Levobupivacaine—Syncope—Doxorubicin—lung cancer	0.000119	0.000276	CcSEcCtD
Levobupivacaine—Diarrhoea—Docetaxel—lung cancer	0.000119	0.000275	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—MMP2—lung cancer	0.000119	0.00109	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—MAP2K1—lung cancer	0.000119	0.00109	CbGpPWpGaD
Levobupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—lung cancer	0.000118	0.00108	CbGpPWpGaD
Levobupivacaine—Palpitations—Doxorubicin—lung cancer	0.000118	0.000272	CcSEcCtD
Levobupivacaine—Hypotension—Methotrexate—lung cancer	0.000117	0.000271	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—lung cancer	0.000117	0.00107	CbGpPWpGaD
Levobupivacaine—Loss of consciousness—Doxorubicin—lung cancer	0.000117	0.00027	CcSEcCtD
Levobupivacaine—SCN4A—Axon guidance—VEGFA—lung cancer	0.000117	0.00107	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000117	0.00107	CbGpPWpGaD
Levobupivacaine—Cough—Doxorubicin—lung cancer	0.000116	0.000269	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—SRC—lung cancer	0.000116	0.00106	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—NRAS—lung cancer	0.000115	0.00106	CbGpPWpGaD
Levobupivacaine—Convulsion—Doxorubicin—lung cancer	0.000115	0.000267	CcSEcCtD
Levobupivacaine—Dizziness—Docetaxel—lung cancer	0.000115	0.000266	CcSEcCtD
Levobupivacaine—Hypertension—Doxorubicin—lung cancer	0.000115	0.000266	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000115	0.00105	CbGpPWpGaD
Levobupivacaine—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000114	0.000264	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—lung cancer	0.000114	0.00105	CbGpPWpGaD
Levobupivacaine—Insomnia—Methotrexate—lung cancer	0.000113	0.000262	CcSEcCtD
Levobupivacaine—Arthralgia—Doxorubicin—lung cancer	0.000113	0.000262	CcSEcCtD
Levobupivacaine—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000113	0.00104	CbGpPWpGaD
Levobupivacaine—Anxiety—Doxorubicin—lung cancer	0.000113	0.000261	CcSEcCtD
Levobupivacaine—Paraesthesia—Methotrexate—lung cancer	0.000113	0.00026	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—VEGFA—lung cancer	0.000113	0.00103	CbGpPWpGaD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.000113	0.00026	CcSEcCtD
Levobupivacaine—Dyspnoea—Methotrexate—lung cancer	0.000112	0.000259	CcSEcCtD
Levobupivacaine—Somnolence—Methotrexate—lung cancer	0.000112	0.000258	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—NRAS—lung cancer	0.000111	0.00102	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PLBD1—lung cancer	0.000111	0.00102	CbGpPWpGaD
Levobupivacaine—Vomiting—Docetaxel—lung cancer	0.000111	0.000256	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—lung cancer	0.00011	0.00101	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—MAPK3—lung cancer	0.00011	0.00101	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Methotrexate—lung cancer	0.00011	0.000255	CcSEcCtD
Levobupivacaine—Confusional state—Doxorubicin—lung cancer	0.00011	0.000253	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—RAF1—lung cancer	0.000109	0.001	CbGpPWpGaD
Levobupivacaine—Decreased appetite—Methotrexate—lung cancer	0.000109	0.000252	CcSEcCtD
Levobupivacaine—Headache—Docetaxel—lung cancer	0.000109	0.000252	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Doxorubicin—lung cancer	0.000109	0.000251	CcSEcCtD
Levobupivacaine—Oedema—Doxorubicin—lung cancer	0.000109	0.000251	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Methotrexate—lung cancer	0.000108	0.00025	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—ERBB2—lung cancer	0.000108	0.000992	CbGpPWpGaD
Levobupivacaine—Infection—Doxorubicin—lung cancer	0.000108	0.00025	CcSEcCtD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000108	0.000986	CbGpPWpGaD
Levobupivacaine—Pain—Methotrexate—lung cancer	0.000107	0.000248	CcSEcCtD
Levobupivacaine—Shock—Doxorubicin—lung cancer	0.000107	0.000247	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—MAPK3—lung cancer	0.000107	0.000977	CbGpPWpGaD
Levobupivacaine—Nervous system disorder—Doxorubicin—lung cancer	0.000107	0.000246	CcSEcCtD
Levobupivacaine—Tachycardia—Doxorubicin—lung cancer	0.000106	0.000245	CcSEcCtD
Levobupivacaine—Skin disorder—Doxorubicin—lung cancer	0.000106	0.000244	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—RAF1—lung cancer	0.000105	0.000967	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—lung cancer	0.000105	0.000964	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—lung cancer	0.000105	0.000964	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—EGFR—lung cancer	0.000105	0.000964	CbGpPWpGaD
Levobupivacaine—Hyperhidrosis—Doxorubicin—lung cancer	0.000105	0.000243	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—ERBB2—lung cancer	0.000104	0.000957	CbGpPWpGaD
Levobupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—lung cancer	0.000104	0.000953	CbGpPWpGaD
Levobupivacaine—Nausea—Docetaxel—lung cancer	0.000103	0.000239	CcSEcCtD
Levobupivacaine—Feeling abnormal—Methotrexate—lung cancer	0.000103	0.000239	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—CYP2E1—lung cancer	0.000103	0.000945	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Methotrexate—lung cancer	0.000103	0.000237	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—SRC—lung cancer	0.000102	0.000938	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—lung cancer	0.000102	0.000938	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP2E1—lung cancer	0.000102	0.000932	CbGpPWpGaD
Levobupivacaine—Hypotension—Doxorubicin—lung cancer	0.000102	0.000235	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—EGFR—lung cancer	0.000101	0.00093	CbGpPWpGaD
Levobupivacaine—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.000101	0.000928	CbGpPWpGaD
Levobupivacaine—Urticaria—Methotrexate—lung cancer	9.97e-05	0.00023	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—lung cancer	9.96e-05	0.000913	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—KRAS—lung cancer	9.93e-05	0.000911	CbGpPWpGaD
Levobupivacaine—Abdominal pain—Methotrexate—lung cancer	9.92e-05	0.000229	CcSEcCtD
Levobupivacaine—Body temperature increased—Methotrexate—lung cancer	9.92e-05	0.000229	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Doxorubicin—lung cancer	9.9e-05	0.000229	CcSEcCtD
Levobupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.89e-05	0.000907	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—lung cancer	9.84e-05	0.000902	CbGpPWpGaD
Levobupivacaine—Insomnia—Doxorubicin—lung cancer	9.83e-05	0.000227	CcSEcCtD
Levobupivacaine—Paraesthesia—Doxorubicin—lung cancer	9.76e-05	0.000226	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.75e-05	0.000894	CbGpPWpGaD
Levobupivacaine—Dyspnoea—Doxorubicin—lung cancer	9.69e-05	0.000224	CcSEcCtD
Levobupivacaine—Somnolence—Doxorubicin—lung cancer	9.66e-05	0.000223	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—KRAS—lung cancer	9.58e-05	0.000878	CbGpPWpGaD
Levobupivacaine—Dyspepsia—Doxorubicin—lung cancer	9.56e-05	0.000221	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—GSTT1—lung cancer	9.46e-05	0.000867	CbGpPWpGaD
Levobupivacaine—Decreased appetite—Doxorubicin—lung cancer	9.44e-05	0.000218	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Doxorubicin—lung cancer	9.38e-05	0.000217	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—GCLC—lung cancer	9.35e-05	0.000857	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2A6—lung cancer	9.35e-05	0.000857	CbGpPWpGaD
Levobupivacaine—Constipation—Doxorubicin—lung cancer	9.29e-05	0.000215	CcSEcCtD
Levobupivacaine—Pain—Doxorubicin—lung cancer	9.29e-05	0.000215	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—MMP9—lung cancer	9.28e-05	0.000851	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Methotrexate—lung cancer	9.24e-05	0.000214	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—lung cancer	9.16e-05	0.00084	CbGpPWpGaD
Levobupivacaine—Asthenia—Methotrexate—lung cancer	9e-05	0.000208	CcSEcCtD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—lung cancer	8.96e-05	0.000822	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—lung cancer	8.96e-05	0.000822	CbGpPWpGaD
Levobupivacaine—Feeling abnormal—Doxorubicin—lung cancer	8.95e-05	0.000207	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—MMP9—lung cancer	8.95e-05	0.000821	CbGpPWpGaD
Levobupivacaine—Gastrointestinal pain—Doxorubicin—lung cancer	8.88e-05	0.000205	CcSEcCtD
Levobupivacaine—Pruritus—Methotrexate—lung cancer	8.88e-05	0.000205	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—EP300—lung cancer	8.8e-05	0.000807	CbGpPWpGaD
Levobupivacaine—Urticaria—Doxorubicin—lung cancer	8.63e-05	0.0002	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—lung cancer	8.62e-05	0.00079	CbGpPWpGaD
Levobupivacaine—Abdominal pain—Doxorubicin—lung cancer	8.59e-05	0.000199	CcSEcCtD
Levobupivacaine—Body temperature increased—Doxorubicin—lung cancer	8.59e-05	0.000199	CcSEcCtD
Levobupivacaine—Diarrhoea—Methotrexate—lung cancer	8.58e-05	0.000198	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—SRC—lung cancer	8.56e-05	0.000785	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTP1—lung cancer	8.5e-05	0.000779	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—EP300—lung cancer	8.49e-05	0.000778	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—lung cancer	8.47e-05	0.000776	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—HRAS—lung cancer	8.44e-05	0.000774	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTP1—lung cancer	8.38e-05	0.000768	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—VEGFA—lung cancer	8.34e-05	0.000764	CbGpPWpGaD
Levobupivacaine—Dizziness—Methotrexate—lung cancer	8.3e-05	0.000192	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—STAT3—lung cancer	8.25e-05	0.000757	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—SRC—lung cancer	8.25e-05	0.000757	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—NRAS—lung cancer	8.23e-05	0.000755	CbGpPWpGaD
Levobupivacaine—SCN10A—Axon guidance—HRAS—lung cancer	8.14e-05	0.000746	CbGpPWpGaD
Levobupivacaine—SCN4A—Axon guidance—IL6—lung cancer	8.08e-05	0.000741	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—VEGFA—lung cancer	8.04e-05	0.000737	CbGpPWpGaD
Levobupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	8.02e-05	0.000735	CbGpPWpGaD
Levobupivacaine—Hypersensitivity—Doxorubicin—lung cancer	8e-05	0.000185	CcSEcCtD
Levobupivacaine—Vomiting—Methotrexate—lung cancer	7.98e-05	0.000184	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—STAT3—lung cancer	7.96e-05	0.00073	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.95e-05	0.000729	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—NRAS—lung cancer	7.94e-05	0.000728	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—MAPK3—lung cancer	7.88e-05	0.000723	CbGpPWpGaD
Levobupivacaine—Headache—Methotrexate—lung cancer	7.86e-05	0.000182	CcSEcCtD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.84e-05	0.000719	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—GSTM1—lung cancer	7.81e-05	0.000716	CbGpPWpGaD
Levobupivacaine—Asthenia—Doxorubicin—lung cancer	7.79e-05	0.00018	CcSEcCtD
Levobupivacaine—SCN10A—Axon guidance—IL6—lung cancer	7.79e-05	0.000714	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—lung cancer	7.7e-05	0.000706	CbGpPWpGaD
Levobupivacaine—Pruritus—Doxorubicin—lung cancer	7.69e-05	0.000178	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—MAPK3—lung cancer	7.6e-05	0.000697	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—EGFR—lung cancer	7.5e-05	0.000688	CbGpPWpGaD
Levobupivacaine—Nausea—Methotrexate—lung cancer	7.45e-05	0.000172	CcSEcCtD
Levobupivacaine—Diarrhoea—Doxorubicin—lung cancer	7.43e-05	0.000172	CcSEcCtD
Levobupivacaine—CYP1A2—Biological oxidations—CYP1A1—lung cancer	7.4e-05	0.000679	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—lung cancer	7.3e-05	0.000669	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—EGFR—lung cancer	7.23e-05	0.000663	CbGpPWpGaD
Levobupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—lung cancer	7.2e-05	0.00066	CbGpPWpGaD
Levobupivacaine—Dizziness—Doxorubicin—lung cancer	7.18e-05	0.000166	CcSEcCtD
Levobupivacaine—SCN4A—Developmental Biology—KRAS—lung cancer	7.09e-05	0.00065	CbGpPWpGaD
Levobupivacaine—Vomiting—Doxorubicin—lung cancer	6.91e-05	0.00016	CcSEcCtD
Levobupivacaine—SCN10A—Developmental Biology—KRAS—lung cancer	6.83e-05	0.000627	CbGpPWpGaD
Levobupivacaine—Headache—Doxorubicin—lung cancer	6.81e-05	0.000157	CcSEcCtD
Levobupivacaine—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.56e-05	0.000601	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AZIN2—lung cancer	6.51e-05	0.000597	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—COL4A3BP—lung cancer	6.51e-05	0.000597	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.47e-05	0.000593	CbGpPWpGaD
Levobupivacaine—Nausea—Doxorubicin—lung cancer	6.45e-05	0.000149	CcSEcCtD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.07e-05	0.000557	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—GSTM1—lung cancer	6.03e-05	0.000553	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—HRAS—lung cancer	6.02e-05	0.000552	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.94e-05	0.000545	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	5.88e-05	0.000539	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—HRAS—lung cancer	5.81e-05	0.000533	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—IL6—lung cancer	5.76e-05	0.000529	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.71e-05	0.000524	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.63e-05	0.000517	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—IL6—lung cancer	5.56e-05	0.00051	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ATP5H—lung cancer	5.54e-05	0.000508	CbGpPWpGaD
Levobupivacaine—CYP1A2—Biological oxidations—POMC—lung cancer	5.52e-05	0.000506	CbGpPWpGaD
Levobupivacaine—SCN4A—Developmental Biology—AKT1—lung cancer	5.32e-05	0.000488	CbGpPWpGaD
Levobupivacaine—SCN10A—Developmental Biology—AKT1—lung cancer	5.13e-05	0.00047	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.09e-05	0.000466	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AZIN2—lung cancer	5.02e-05	0.000461	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—COL4A3BP—lung cancer	5.02e-05	0.000461	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PLBD1—lung cancer	4.93e-05	0.000452	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	4.85e-05	0.000445	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HSD17B10—lung cancer	4.51e-05	0.000414	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ATP5H—lung cancer	4.27e-05	0.000392	CbGpPWpGaD
Levobupivacaine—CYP3A4—Biological oxidations—POMC—lung cancer	4.26e-05	0.000391	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CKB—lung cancer	4.2e-05	0.000385	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM2—lung cancer	3.94e-05	0.000362	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CNDP2—lung cancer	3.94e-05	0.000362	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—MTMR3—lung cancer	3.84e-05	0.000352	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PLBD1—lung cancer	3.81e-05	0.000349	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PGAM1—lung cancer	3.74e-05	0.000343	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2A7—lung cancer	3.57e-05	0.000327	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—SDC4—lung cancer	3.49e-05	0.00032	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HSD17B10—lung cancer	3.48e-05	0.000319	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CKB—lung cancer	3.24e-05	0.000297	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—RRM1—lung cancer	3.18e-05	0.000292	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA3—lung cancer	3.18e-05	0.000292	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM2—lung cancer	3.04e-05	0.000279	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CNDP2—lung cancer	3.04e-05	0.000279	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—B4GALT5—lung cancer	2.99e-05	0.000274	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—MTMR3—lung cancer	2.96e-05	0.000272	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA4—lung cancer	2.91e-05	0.000267	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PGAM1—lung cancer	2.89e-05	0.000265	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.84e-05	0.000261	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA2—lung cancer	2.83e-05	0.00026	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2A7—lung cancer	2.75e-05	0.000252	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTA1—lung cancer	2.73e-05	0.000251	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCC3—lung cancer	2.7e-05	0.000248	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—SDC4—lung cancer	2.69e-05	0.000247	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKR1C1—lung cancer	2.62e-05	0.00024	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—UGT1A1—lung cancer	2.54e-05	0.000233	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA3—lung cancer	2.45e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—RRM1—lung cancer	2.45e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GNG11—lung cancer	2.45e-05	0.000225	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.44e-05	0.000224	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALDOA—lung cancer	2.33e-05	0.000214	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—B4GALT5—lung cancer	2.31e-05	0.000212	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NCOA3—lung cancer	2.27e-05	0.000208	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA4—lung cancer	2.24e-05	0.000206	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.23e-05	0.000204	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ADCY1—lung cancer	2.2e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCG2—lung cancer	2.2e-05	0.000202	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA2—lung cancer	2.19e-05	0.000201	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ENO2—lung cancer	2.16e-05	0.000198	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—HPGDS—lung cancer	2.16e-05	0.000198	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PPP2R1B—lung cancer	2.15e-05	0.000197	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.12e-05	0.000194	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTA1—lung cancer	2.11e-05	0.000193	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTT1—lung cancer	2.1e-05	0.000192	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCC3—lung cancer	2.09e-05	0.000191	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GCLC—lung cancer	2.07e-05	0.00019	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2A6—lung cancer	2.07e-05	0.00019	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.06e-05	0.000189	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKR1C1—lung cancer	2.02e-05	0.000185	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ENO1—lung cancer	1.96e-05	0.00018	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—UGT1A1—lung cancer	1.96e-05	0.00018	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.96e-05	0.000179	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.93e-05	0.000177	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GNG11—lung cancer	1.89e-05	0.000173	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALDOA—lung cancer	1.8e-05	0.000165	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP2E1—lung cancer	1.76e-05	0.000162	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NCOA3—lung cancer	1.75e-05	0.00016	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—NQO1—lung cancer	1.74e-05	0.00016	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.71e-05	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ADCY1—lung cancer	1.7e-05	0.000156	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCG2—lung cancer	1.7e-05	0.000156	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.69e-05	0.000155	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—HPGDS—lung cancer	1.67e-05	0.000153	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ENO2—lung cancer	1.67e-05	0.000153	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.66e-05	0.000152	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTT1—lung cancer	1.62e-05	0.000148	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GCLC—lung cancer	1.6e-05	0.000147	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2A6—lung cancer	1.6e-05	0.000147	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—STK11—lung cancer	1.57e-05	0.000144	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ENO1—lung cancer	1.52e-05	0.000139	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.47e-05	0.000135	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTP1—lung cancer	1.45e-05	0.000133	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CAT—lung cancer	1.41e-05	0.00013	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.41e-05	0.000129	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ABCB1—lung cancer	1.38e-05	0.000126	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP2E1—lung cancer	1.36e-05	0.000125	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—TYMS—lung cancer	1.35e-05	0.000124	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—NQO1—lung cancer	1.34e-05	0.000123	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—GSTM1—lung cancer	1.34e-05	0.000122	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CYP1A1—lung cancer	1.27e-05	0.000116	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ERCC2—lung cancer	1.26e-05	0.000115	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—STK11—lung cancer	1.21e-05	0.000111	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTP1—lung cancer	1.12e-05	0.000103	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CAT—lung cancer	1.09e-05	0.0001	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—APOA1—lung cancer	1.09e-05	9.96e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ABCB1—lung cancer	1.06e-05	9.73e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—TYMS—lung cancer	1.04e-05	9.56e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.04e-05	9.54e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—GSTM1—lung cancer	1.03e-05	9.45e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CG—lung cancer	9.91e-06	9.09e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CYP1A1—lung cancer	9.77e-06	8.96e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ERCC2—lung cancer	9.69e-06	8.88e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—POMC—lung cancer	9.44e-06	8.65e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—CREBBP—lung cancer	9.19e-06	8.43e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CD—lung cancer	8.72e-06	7.99e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—ALB—lung cancer	8.6e-06	7.89e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—APOA1—lung cancer	8.38e-06	7.69e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CG—lung cancer	7.65e-06	7.02e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CB—lung cancer	7.6e-06	6.97e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTGS2—lung cancer	7.53e-06	6.9e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—POMC—lung cancer	7.28e-06	6.68e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—CREBBP—lung cancer	7.09e-06	6.51e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CD—lung cancer	6.73e-06	6.17e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—ALB—lung cancer	6.64e-06	6.09e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PTEN—lung cancer	6.56e-06	6.02e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—EP300—lung cancer	6.26e-06	5.74e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CB—lung cancer	5.86e-06	5.38e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTGS2—lung cancer	5.81e-06	5.33e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PTEN—lung cancer	5.07e-06	4.65e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—EP300—lung cancer	4.83e-06	4.43e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—PIK3CA—lung cancer	4.63e-06	4.25e-05	CbGpPWpGaD
Levobupivacaine—CYP1A2—Metabolism—AKT1—lung cancer	3.78e-06	3.47e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—PIK3CA—lung cancer	3.57e-06	3.28e-05	CbGpPWpGaD
Levobupivacaine—CYP3A4—Metabolism—AKT1—lung cancer	2.92e-06	2.68e-05	CbGpPWpGaD
